VANGUARD GROUP INC 13D and 13G filings for ACADIA Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:06 pm Sale | 2026-03-13 | 13G | ACADIA PHARMACEUTICALS INC ACAD | VANGUARD GROUP INC | 0 0.000% | -13,396,009 (Position Closed) | Filing |
| 2024-02-13 4:56 pm Purchase | 2023-12-29 | 13G | ACADIA PHARMACEUTICALS INC ACAD | VANGUARD GROUP INC | 13,396,009 8.160% | 116,234 (+0.88%) | Filing |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | ACADIA PHARMACEUTICALS INC ACAD | VANGUARD GROUP INC | 13,279,775 8.200% | 964,409 (+7.83%) | Filing |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | ACADIA PHARMACEUTICALS INC ACAD | VANGUARD GROUP INC | 12,315,366 7.660% | 1,709,593 (+16.12%) | Filing |